IFNG and glioblastoma: T98G glioblastoma cells were transfected with a plasmid encoding T-antigen and were treated with IL-2, Rantes, IFN-γ, IL-1β, IL-13 and MCP1 at 12, 24, and 36hrs post-transfection.